HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reciprocal regulation of ATPgammaS-induced monocyte chemoattractant protein-1 production by ERK and p38 MAP kinases in rat corticostriatal slice cultures.

Abstract
Monocyte chemoattractant protein-1 (MCP-1, CCL2) is a well-defined chemokine implicated in the pathology of various neurodegenerative diseases and brain injuries, such as Alzheimer's disease, multiple sclerosis, stroke, and traumatic injury. We investigated the effect of the activation of P2 purinoceptors on MCP-1 production in rat corticostriatal slice cultures. Treatment with adenosine 5'-O-(3-thiotriphosphate) (ATPgammaS), a hydrolysis-resistant adenosine triphosphate (ATP) analog, induced MCP-1 production in astrocytes. The induction was in a concentration-dependent manner and was antagonized by a P2 purinoceptor antagonist pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid. The inhibition of an extracellular signal-regulated kinase (ERK) pathway by PD98059 and U0126 significantly suppressed ATPgammaS-induced MCP-1 mRNA expression and protein production, while inhibition of c-Jun N-terminal kinase by SP600125 resulted in the partial suppression. Conversely, SB203580, a p38 mitogen-activated protein (MAP) kinase inhibitor, significantly enhanced ATPgammaS-induced MCP-1 production. Similar effects of ERK and p38 MAP kinase inhibitors on MCP-1 production were observed in the slices stimulated by ATP and BzATP. These results demonstrate that astrocytic MCP-1 production induced by P2 purinoceptor stimulation is reciprocally regulated by ERK and p38 MAP kinases in the organotypic slice cultures.
AuthorsTakahiro Katayama, Misato Ito, Shuji Kaneko, Masamichi Satoh, Takashi Uehara, Masabumi Minami
JournalJournal of neuroscience research (J Neurosci Res) Vol. 87 Issue 7 Pg. 1573-81 (May 15 2009) ISSN: 1097-4547 [Electronic] United States
PMID19125410 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2009 Wiley-Liss, Inc.
Chemical References
  • Ccl2 protein, rat
  • Chemokine CCL2
  • Enzyme Inhibitors
  • RNA, Messenger
  • adenosine 5'-O-(3-thiotriphosphate)
  • 3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate
  • Adenosine Triphosphate
  • Extracellular Signal-Regulated MAP Kinases
  • JNK Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Adenosine Triphosphate (analogs & derivatives, metabolism)
  • Animals
  • Astrocytes (drug effects, physiology)
  • Cells, Cultured
  • Cerebrum (physiology)
  • Chemokine CCL2 (metabolism)
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors (pharmacology)
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Gene Expression (drug effects)
  • In Vitro Techniques
  • JNK Mitogen-Activated Protein Kinases (metabolism)
  • MAP Kinase Signaling System (drug effects, physiology)
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Wistar
  • Time Factors
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: